0000899243-21-008055.txt : 20210224 0000899243-21-008055.hdr.sgml : 20210224 20210224174228 ACCESSION NUMBER: 0000899243-21-008055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210222 FILED AS OF DATE: 20210224 DATE AS OF CHANGE: 20210224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mamluk Roni CENTRAL INDEX KEY: 0001647053 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39279 FILM NUMBER: 21675164 MAIL ADDRESS: STREET 1: CHIASMA, INC. STREET 2: 60WELLS AVENUE CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001797336 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823578375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: (857) 444-0553 MAIL ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-22 0 0001797336 Ayala Pharmaceuticals, Inc. AYLA 0001647053 Mamluk Roni OPPENHEIMER 4 REHOVOT L3 7670104 ISRAEL 1 1 0 0 President & CEO Common Stock 2021-02-22 4 S 0 15200 19.8561 D 163271 D Common Stock 2021-02-23 4 S 0 7126 17.8899 D 156145 D Common Stock 2021-02-24 4 S 0 10800 17.3999 D 145345 D The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan. /s/ Roni Mamluk, Ph.D. 2021-02-24